Tune into this episode of PwC's Next in Health to hear Strategy& Principal, Igor Belokrinitsky and PwC's Health Industries Vice Chair, Jenny Colapietro, in discussion with PwC's Pharmaceutical and Life Sciences Research and Development Principals, Anup Kharode and Brian Slizgi, on the evolution of the clinical trial delivery model, including:

  • Impact of COVID-19 on clinical trials and research
  • Emerging trends and disruptors
  • Implications for clinical research organizations (CROs) and the broader pharmaceutical industry
  • The future of decentralized clinical trials